Today: 17 May 2026
Bloom Energy Stock Faces a Big Test as BlackRock’s 8.2% Stake Meets Oracle AI Power Bet

Bloom Energy Stock Faces a Big Test as BlackRock’s 8.2% Stake Meets Oracle AI Power Bet

SAN JOSE, April 26, 2026, 12:08 PDT

BlackRock has taken a passive 8.2% stake in Bloom Energy Corporation, according to an amended ownership filing dated April 24. The disclosure comes just ahead of the fuel-cell company’s first-quarter report, set for two days later. BlackRock’s filing lists 22,911,282 Class A shares owned, with sole voting rights attached to 22,035,523 of those.

Timing’s key here. Bloom is set to report first-quarter numbers after the bell on April 28. Investors will be tuned in less for the actual quarterly figures and more for what management has to say on Oracle, how quickly backlog is being converted, and the trajectory of power demand out of AI data centers.

Bloom shares finished Friday at $231.17, slipping 2.7%. Earlier in the day, they peaked at $246.02. The recent action—steep and fast—means that even new institutional filings drop into a market that’s demanding evidence, not just another run of AI-fueled headlines.

BlackRock has updated its passive stake in Bloom through a Schedule 13G/A amendment, a move signaling institutional rather than activist intent. The firm confirmed it holds the shares in the normal course of business, not to seek control or push changes at Bloom.

Oracle continues to be the sticking point. On April 13, Bloom said Oracle plans to buy as much as 2.8 gigawatts of Bloom’s fuel-cell systems through a master services agreement. Of that, 1.2 gigawatts are already under contract, with deployment happening now at U.S. sites.

One gigawatt equals 1,000 megawatts. Fuel cells convert hydrogen or other fuels into electricity via chemical reactions—a selling point for data-center operators who’d rather install on-site power than wait out lengthy grid upgrades in stressed regions. According to the U.S. Energy Department, fuel cells are devices that generate electricity from chemical energy. Bloom, for its part, says its solid-oxide technology is used by data centers, semiconductor manufacturers, utilities, and other industrial sectors.

Mahesh Thiagarajan, executive vice president at Oracle Cloud Infrastructure, said the firms were “quickly meeting the demands” of U.S. customers. Bloom Chief Commercial Officer Aman Joshi described the partnership as “defining a shared vision” for energy and AI infrastructure. Bloom Energy

Analyst opinions have split. Jefferies’ Dushyant Ailani bumped Bloom up to Hold from Underperform, pointing to the Oracle order. He sees a potential 20% revenue beat for 2026 and a 51% upside in 2027 if the backlog and Oracle demand materialize as sales. But his note flags a catch: hitting 2026 volume could mean maxing out capacity and relying on finished goods inventory.

Several analysts moved their targets up. Citigroup’s Vikram Bagri bumped his price target to $229, sticking with a neutral stance. UBS’s Manav Gupta marked his up to $251 and maintained a buy, while Baird went to $242, still rating the stock outperform. The range says plenty—order books look firmer, but much of that optimism is already baked into the share price.

The competitive landscape keeps tightening. Investors are still eyeing Plug Power and Ballard Power Systems as fuel-cell and hydrogen rivals, yet Bloom stands apart on market cap—about $54.3 billion as of Friday, towering over Plug’s $3.6 billion and Ballard’s $982 million. With the Oracle deal, Bloom has shifted closer to a pure hyperscale data-center power story than most names in the space.

Bloom started the quarter on a roll. The company posted 2025 revenue of $2.02 billion, a jump of 37.3% over 2024. For 2026, Bloom is targeting revenue between $3.1 billion and $3.3 billion, with non-GAAP EPS in a $1.33 to $1.48 range. Whether Bloom can actually translate its expanding backlog into better margins and cash flow—beyond just more shipments—will be on the line with Tuesday’s results.

Still, there are clear risks here. Just 1.2 gigawatts from the Oracle deal has actually been locked in; the much-touted 2.8-gigawatt figure remains merely “up to.” Another filing revealed Bloom handed Oracle a warrant covering as many as 3,531,073 Class A shares at $113.28 apiece, with the option open until Oct. 9, 2026. If Oracle exercises it, existing shareholders could see dilution. SEC

Bloom itself has pointed to risks like tight supply, limits on manufacturing, holdups in utility hookups, recognizing its backlog, and any pause in AI data-center spending. Those are the issues behind both the BlackRock filing and the Oracle agreement: is Bloom actually cementing its role as a critical power player for AI, or is the market pricing in more than the company can realistically deliver?

Stock Market Today

  • Realty Income (O) Faces Mixed Valuation Signals After Solid Q1 and Raised AFFO Guidance
    May 17, 2026, 12:49 AM EDT. Realty Income (O) reported strong Q1 results and boosted its Adjusted Funds From Operations (AFFO) guidance, alongside its 671st monthly dividend, equity issuance, and buybacks. Despite these positive developments, its share price fell 6.1% over 30 days and 6.9% over 90 days. The stock trades at a high price-to-earnings (P/E) ratio of 50.9x, well above peer averages, suggesting valuation risk. However, a dividend-focused valuation model indicates the stock is 13.8% undervalued with a fair value of $70.93 compared to the current $61.12 share price. Investors should weigh steady dividend growth and operating margins against rising funding costs and regional revenue risks in Realty Income's western markets.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
AeroVironment Stock Watch: Navy Laser Test Puts AVAV Back in Drone-Defense Focus
Previous Story

AeroVironment Stock Watch: Navy Laser Test Puts AVAV Back in Drone-Defense Focus

Blackstone Just Put $16 Billion Behind Oracle’s AI Buildout. The Hard Part Comes Next
Next Story

Blackstone Just Put $16 Billion Behind Oracle’s AI Buildout. The Hard Part Comes Next

Go toTop